THE WILL EDMONDS CLINICAL RESEARCH FUND

Registered charity 235573 · accounts filings on the Charity Commission register

To us ethe income to award a Fellowship in clinical research in hospitals in the Metropolitan area of London. The research must concern diseases such as usually treated at a General Hospital, excluding tropical and rare diseases.

Causes: Education/training · website · Get email alerts

Latest income
£39k
Latest spending
£2k
Registered
1964
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that the charity reported a net unrestricted operating loss of £181k for the year ended 31 December 2024, though a surplus of £377k was achieved after adjusting for transfers from trust funds. Free reserves net of lease liabilities amounted to £13m, representing close to four months of unrestricted operational expenditure, which the trustees consider a significant improvement on the prior year. The Board of Trustees confirmed that adequate levels of cash and reserves exist to support the charity's operations on a going concern basis through at least September 2026.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Related-party transaction: Donations received from trustees
Donations totalling £333 (2023: £933) were received from two trustees in the year (2023: 3). — page 77
The total transactions in the year from the RCP Regent’s Park Limited to the RCP totalled £2,356k, with the RCP as at 31 December 2024 owing the trading company £1,648k in relation to an intercompany balance.
Per its FY2024 accounts as filed with the Charity Commission.
Related-party transaction: Trading subsidiary transactions
Donations totalling £333 (2023: £933) were received from two trustees in the year (2023: 3). — page 77
The total transactions in the year from the RCP Regent’s Park Limited to the RCP totalled £2,356k, with the RCP as at 31 December 2024 owing the trading company £1,648k in relation to an intercompany balance.
Per its FY2024 accounts as filed with the Charity Commission.
Governance: The King's Fund independent learning review commissioned following EGM concerns regarding governance, leadership, and culture.
Following the EGM, we commissioned The King’s Fund to undertake an independent review to support our learning. We accepted the report’s recommendations in full and developed an action plan to implement them. — page 5
Per its FY2024 accounts as filed with the Charity Commission.

Accounts audited by Crowe U.K. LLP. Discloses 3 of 6 completeness components.

Public profiles (found on the charity’s own website): facebook · instagram · linkedin

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout London

Income and spending

Financial year endIncomeSpending
31/12/2024£39k£2k
31/12/2023£12k£2k
31/12/2022£8k£2k
31/12/2021£7k£3k
31/12/2020£3k£1k

Common questions

Is THE WILL EDMONDS CLINICAL RESEARCH FUND financially healthy?

Per its FY2024 accounts: The accounts state that the charity reported a net unrestricted operating loss of £181k for the year ended 31 December 2024, though a surplus of £377k was achieved after adjusting for transfers from trust funds. Free reserves net of lease liabilities amounted to £13m, representing close to four months of unrestricted operational expenditure, which the trustees consider a significant improvement on the prior year. The Board of Trustees confirmed that adequate levels of cash and reserves exist to support the charity's operations on a going concern basis through at least September 2026. Its FY2024 accounts were audited by Crowe U.K. LLP.